+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Ureteroscopy Market Size, Share & Industry Trends Analysis Report By End User, By Product, By Application, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 191 Pages
  • February 2023
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5752790
The Global Ureteroscopy Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 5.2% CAGR during the forecast period.

A specific type of endoscope called a ureteroscope is rigid, flexible, or semi-flexible, with a camera and light source at one end. Endoscopes, known as ureteroscopes are used to see within the urinary tract and examine it. Particularly long and narrow, ureteroscopy can be placed into the urethra, into the bladder, and into the ureter. These endoscopes are used for visual inspections and tool-assisted ureter internal examinations.



Urinary strictures, kidney cancer, kidney stones, and upper urinary tract urothelial carcinoma can all be detected and treated using this method. Several varieties of ureteroscopic are available, including flexible, stiff, semi-rigid, single-use, and double-channel ureteroscopes. A small telescope called a ureteroscope is sent through the bladder and urethra and up the ureter to the spot where the stone is placed during ureteroscopy, a treatment used to treat kidney stones.

The surgery typically takes one to three hours and is usually done while the patient is under general anesthesia. Smaller stones can usually be removed whole from the ureter by being captured in a basket device. If the stone is huge or the ureter's diameter is small, it must then be broken apart, usually with a laser. The stone is divided into tiny bits before these fragments are removed. The ureter may enlarge as a result of the ureteroscope's passage. To ensure that the kidney drains urine effectively, it may be essential to temporarily leave a small tube known as a ureteral stent inside the ureter.

COVID-19 Impact Analysis

The COVID-19 pandemic caused supply chains in a number of end-user industries, including industrial, healthcare, and medical devices. Moreover, a decline in urology hospital visits and fewer urology hospitals throughout thepandemic may limit the use of ureteroscope devices and restrain market expansion. Also, the lockdown's impact on urological surgeries caused a reduction in the demand for ureteroscopes, which also restrained market expansion. Because of the COVID-19 pandemic, people have put off elective surgeries. Due to the serious risk of viral transmission, people have also put delayed treating kidney stones for a long. In addition, emerging countries are expected to experience extremely robust sales of advanced ureteroscope technology.

Market Growth Factors

Rising old aged population across the globe

According to World Health Organization; one in six people globally will be 60 or older by 2030. By this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The proportion of people above 600 will double itself by 2050. Between 2020 and 2050, the number of people 80 or older is projected to treble, reaching 426 million. Although population aging, or the movement in a country's population's distribution towards older ages, began in high-income nations, it is currently low- and middle-income nations that are going through the most significant transformation. This will drive up demand for ureteroscopy during the anticipated period.

Rising number of less invasive surgeries

Minimally invasive surgeries are considerably less dreadful than conventional open surgeries. Traditional operations performed with traditional laparoscopic tools can be challenging and upsetting. Specialized, compact equipment is used throughout the process, and minimally invasive surgical cameras are inserted through smaller incisions. Patients who undergo minimally invasive procedures recover more rapidly and with less discomfort. Minimally invasive surgical procedures are gaining popularity because they need fewer hospital stays, are more precise, leave fewer scars, are less painful, and require smaller incisions.



Market Restraining Factors

Possible side effects of ureteroscopes

Stent pain is the most prevalent risk or complaint after ureteroscopy, occurring in manypatients who had a stent placed during a ureteroscopy. A stent is a flexible plastic tube that permits the kidney to drain to the bladder despite edema or occlusion. It is around half the size of IV tubings. In addition to allowing urine to pass up from the bladder to the kidney during urination, the stent can 'rub'on the inside of the bladder, giving the sensation of needing to urinate or having an overactive bladder. This can result in symptoms ranging from a warm, tingling sensation to severe pain in the affected flank.

Product Outlook

Based on product, the ureteroscopy market is segmented into flexible and semi- rigid. In 2021, the semi-rigid segment covered a considerable revenue share in the urethroscopy market. A semi-rigid ureteroscope is an instrument used to view the interior of the urinary tract. A ureteroscope is used to see into the ureters, the tubes that convey urine from the kidneys to the bladder, which are longer and thinner than the cystoscope. Moreover, a stone in the ureter can be seen, fragmented, and removed by the doctor using a semi-rigid ureteroscope. Thus, using semi-rigid to look within the urinary tract, along with other advantages, is anticipated to drive the segment's expansion.

Application Outlook

On the basis of application, the ureteroscopy market is divided into urolithiasis, kidney cancer, urinary stricture and others. In 2021, the urolithiasis segment witnessed the largest revenue share in the ureteroscopy market. This is due to the elevated prevalence of chronic kidney disorders and kidney stone development, particularly in adults, raising the demand for ureteroscopes. 'Urolithiasis'refers to calculi or stones that develop in the urinary tract. The urinary system, primarily the kidneys or ureters but often the bladder and/or urethra, develop calcifications due to this illness. These elements will boost ureteroscopy utilization and fuel the segment's growth.

End-user Outlook

By end user, the ureteroscopy market is classified into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the ureteroscopy market with the maximum revenue share in 2021. The adoption of technologically improved ureteroscope devices, a well-equipped infrastructure, increased purchasing power, and an increase in patient admission all contribute to this. Also, a rise in patients' preference for hospitals, which properly administer treatments under the supervision of knowledgeable doctors, is another factor driving the segment's expansion.

Regional Outlook

Region-wise, the ureteroscopy market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, the North America region generated the maximum revenue share in the ureteroscopy market. The availability of cutting-edge ureteroscopes increased frequency of kidney problems, and increased awareness of renal diseases are projected to propel the market in the region. The market is also growing due to other factors like advantageous reimbursement policies, patient consciousness, and the use of cutting-edge instruments. The industry is also driven by increased pediatric stone cases in the area.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.

Scope of the Study

By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Product

  • Flexible
  • Semi- Rigid

By Application

  • Urolithiasis
  • Urinary Stricture
  • Kidney Cancer
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Boston Scientific Corporation
  • Olympus Corporation
  • Hoya Corporation
  • Steris PLC
  • Stryker Corporation
  • Advin Health Care
  • Karl Storz SE & Co. KG
  • Richard Wolf GmbH
  • Cliniva Healthcare
  • OTU Medical Inc.

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Ureteroscopy Market, by End User
1.4.2 Global Ureteroscopy Market, by Product
1.4.3 Global Ureteroscopy Market, by Application
1.4.4 Global Ureteroscopy Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Ureteroscopy Market by End User
3.1 Global Hospitals Market by Region
3.2 Global Ambulatory Surgical Centers Market by Region
3.3 Global Others Market by Region

Chapter 4. Global Ureteroscopy Market by Product
4.1 Global Flexible Market by Region
4.2 Global Semi- Rigid Market by Region

Chapter 5. Global Ureteroscopy Market by Application
5.1 Global Urolithiasis Market by Region
5.2 Global Urinary Stricture Market by Region
5.3 Global Kidney Cancer Market by Region
5.4 Global Others Market by Region

Chapter 6. Global Ureteroscopy Market by Region
6.1 North America Ureteroscopy Market
6.1.1 North America Ureteroscopy Market by End User
6.1.1.1 North America Hospitals Market by Country
6.1.1.2 North America Ambulatory Surgical Centers Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Ureteroscopy Market by Product
6.1.2.1 North America Flexible Market by Country
6.1.2.2 North America Semi- Rigid Market by Country
6.1.3 North America Ureteroscopy Market by Application
6.1.3.1 North America Urolithiasis Market by Country
6.1.3.2 North America Urinary Stricture Market by Country
6.1.3.3 North America Kidney Cancer Market by Country
6.1.3.4 North America Others Market by Country
6.1.4 North America Ureteroscopy Market by Country
6.1.4.1 US Ureteroscopy Market
6.1.4.1.1 US Ureteroscopy Market by End User
6.1.4.1.2 US Ureteroscopy Market by Product
6.1.4.1.3 US Ureteroscopy Market by Application
6.1.4.2 Canada Ureteroscopy Market
6.1.4.2.1 Canada Ureteroscopy Market by End User
6.1.4.2.2 Canada Ureteroscopy Market by Product
6.1.4.2.3 Canada Ureteroscopy Market by Application
6.1.4.3 Mexico Ureteroscopy Market
6.1.4.3.1 Mexico Ureteroscopy Market by End User
6.1.4.3.2 Mexico Ureteroscopy Market by Product
6.1.4.3.3 Mexico Ureteroscopy Market by Application
6.1.4.4 Rest of North America Ureteroscopy Market
6.1.4.4.1 Rest of North America Ureteroscopy Market by End User
6.1.4.4.2 Rest of North America Ureteroscopy Market by Product
6.1.4.4.3 Rest of North America Ureteroscopy Market by Application
6.2 Europe Ureteroscopy Market
6.2.1 Europe Ureteroscopy Market by End User
6.2.1.1 Europe Hospitals Market by Country
6.2.1.2 Europe Ambulatory Surgical Centers Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Ureteroscopy Market by Product
6.2.2.1 Europe Flexible Market by Country
6.2.2.2 Europe Semi- Rigid Market by Country
6.2.3 Europe Ureteroscopy Market by Application
6.2.3.1 Europe Urolithiasis Market by Country
6.2.3.2 Europe Urinary Stricture Market by Country
6.2.3.3 Europe Kidney Cancer Market by Country
6.2.3.4 Europe Others Market by Country
6.2.4 Europe Ureteroscopy Market by Country
6.2.4.1 Germany Ureteroscopy Market
6.2.4.1.1 Germany Ureteroscopy Market by End User
6.2.4.1.2 Germany Ureteroscopy Market by Product
6.2.4.1.3 Germany Ureteroscopy Market by Application
6.2.4.2 UK Ureteroscopy Market
6.2.4.2.1 UK Ureteroscopy Market by End User
6.2.4.2.2 UK Ureteroscopy Market by Product
6.2.4.2.3 UK Ureteroscopy Market by Application
6.2.4.3 France Ureteroscopy Market
6.2.4.3.1 France Ureteroscopy Market by End User
6.2.4.3.2 France Ureteroscopy Market by Product
6.2.4.3.3 France Ureteroscopy Market by Application
6.2.4.4 Russia Ureteroscopy Market
6.2.4.4.1 Russia Ureteroscopy Market by End User
6.2.4.4.2 Russia Ureteroscopy Market by Product
6.2.4.4.3 Russia Ureteroscopy Market by Application
6.2.4.5 Spain Ureteroscopy Market
6.2.4.5.1 Spain Ureteroscopy Market by End User
6.2.4.5.2 Spain Ureteroscopy Market by Product
6.2.4.5.3 Spain Ureteroscopy Market by Application
6.2.4.6 Italy Ureteroscopy Market
6.2.4.6.1 Italy Ureteroscopy Market by End User
6.2.4.6.2 Italy Ureteroscopy Market by Product
6.2.4.6.3 Italy Ureteroscopy Market by Application
6.2.4.7 Rest of Europe Ureteroscopy Market
6.2.4.7.1 Rest of Europe Ureteroscopy Market by End User
6.2.4.7.2 Rest of Europe Ureteroscopy Market by Product
6.2.4.7.3 Rest of Europe Ureteroscopy Market by Application
6.3 Asia Pacific Ureteroscopy Market
6.3.1 Asia Pacific Ureteroscopy Market by End User
6.3.1.1 Asia Pacific Hospitals Market by Country
6.3.1.2 Asia Pacific Ambulatory Surgical Centers Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Ureteroscopy Market by Product
6.3.2.1 Asia Pacific Flexible Market by Country
6.3.2.2 Asia Pacific Semi- Rigid Market by Country
6.3.3 Asia Pacific Ureteroscopy Market by Application
6.3.3.1 Asia Pacific Urolithiasis Market by Country
6.3.3.2 Asia Pacific Urinary Stricture Market by Country
6.3.3.3 Asia Pacific Kidney Cancer Market by Country
6.3.3.4 Asia Pacific Others Market by Country
6.3.4 Asia Pacific Ureteroscopy Market by Country
6.3.4.1 China Ureteroscopy Market
6.3.4.1.1 China Ureteroscopy Market by End User
6.3.4.1.2 China Ureteroscopy Market by Product
6.3.4.1.3 China Ureteroscopy Market by Application
6.3.4.2 Japan Ureteroscopy Market
6.3.4.2.1 Japan Ureteroscopy Market by End User
6.3.4.2.2 Japan Ureteroscopy Market by Product
6.3.4.2.3 Japan Ureteroscopy Market by Application
6.3.4.3 India Ureteroscopy Market
6.3.4.3.1 India Ureteroscopy Market by End User
6.3.4.3.2 India Ureteroscopy Market by Product
6.3.4.3.3 India Ureteroscopy Market by Application
6.3.4.4 South Korea Ureteroscopy Market
6.3.4.4.1 South Korea Ureteroscopy Market by End User
6.3.4.4.2 South Korea Ureteroscopy Market by Product
6.3.4.4.3 South Korea Ureteroscopy Market by Application
6.3.4.5 Singapore Ureteroscopy Market
6.3.4.5.1 Singapore Ureteroscopy Market by End User
6.3.4.5.2 Singapore Ureteroscopy Market by Product
6.3.4.5.3 Singapore Ureteroscopy Market by Application
6.3.4.6 Malaysia Ureteroscopy Market
6.3.4.6.1 Malaysia Ureteroscopy Market by End User
6.3.4.6.2 Malaysia Ureteroscopy Market by Product
6.3.4.6.3 Malaysia Ureteroscopy Market by Application
6.3.4.7 Rest of Asia Pacific Ureteroscopy Market
6.3.4.7.1 Rest of Asia Pacific Ureteroscopy Market by End User
6.3.4.7.2 Rest of Asia Pacific Ureteroscopy Market by Product
6.3.4.7.3 Rest of Asia Pacific Ureteroscopy Market by Application
6.4 LAMEA Ureteroscopy Market
6.4.1 LAMEA Ureteroscopy Market by End User
6.4.1.1 LAMEA Hospitals Market by Country
6.4.1.2 LAMEA Ambulatory Surgical Centers Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Ureteroscopy Market by Product
6.4.2.1 LAMEA Flexible Market by Country
6.4.2.2 LAMEA Semi- Rigid Market by Country
6.4.3 LAMEA Ureteroscopy Market by Application
6.4.3.1 LAMEA Urolithiasis Market by Country
6.4.3.2 LAMEA Urinary Stricture Market by Country
6.4.3.3 LAMEA Kidney Cancer Market by Country
6.4.3.4 LAMEA Others Market by Country
6.4.4 LAMEA Ureteroscopy Market by Country
6.4.4.1 Brazil Ureteroscopy Market
6.4.4.1.1 Brazil Ureteroscopy Market by End User
6.4.4.1.2 Brazil Ureteroscopy Market by Product
6.4.4.1.3 Brazil Ureteroscopy Market by Application
6.4.4.2 Argentina Ureteroscopy Market
6.4.4.2.1 Argentina Ureteroscopy Market by End User
6.4.4.2.2 Argentina Ureteroscopy Market by Product
6.4.4.2.3 Argentina Ureteroscopy Market by Application
6.4.4.3 UAE Ureteroscopy Market
6.4.4.3.1 UAE Ureteroscopy Market by End User
6.4.4.3.2 UAE Ureteroscopy Market by Product
6.4.4.3.3 UAE Ureteroscopy Market by Application
6.4.4.4 Saudi Arabia Ureteroscopy Market
6.4.4.4.1 Saudi Arabia Ureteroscopy Market by End User
6.4.4.4.2 Saudi Arabia Ureteroscopy Market by Product
6.4.4.4.3 Saudi Arabia Ureteroscopy Market by Application
6.4.4.5 South Africa Ureteroscopy Market
6.4.4.5.1 South Africa Ureteroscopy Market by End User
6.4.4.5.2 South Africa Ureteroscopy Market by Product
6.4.4.5.3 South Africa Ureteroscopy Market by Application
6.4.4.6 Nigeria Ureteroscopy Market
6.4.4.6.1 Nigeria Ureteroscopy Market by End User
6.4.4.6.2 Nigeria Ureteroscopy Market by Product
6.4.4.6.3 Nigeria Ureteroscopy Market by Application
6.4.4.7 Rest of LAMEA Ureteroscopy Market
6.4.4.7.1 Rest of LAMEA Ureteroscopy Market by End User
6.4.4.7.2 Rest of LAMEA Ureteroscopy Market by Product
6.4.4.7.3 Rest of LAMEA Ureteroscopy Market by Application

Chapter 7. Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Acquisition and Mergers:
7.1.5.3 Approvals and Trials:
7.2 Olympus Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Recent strategies and developments:
7.2.4.1 Acquisition and Mergers:
7.3 Hoya Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Steris PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Advin Health Care
7.6.1 Company Overview
7.7 Karl Storz SE & Co. KG
7.7.1 Company Overview
7.8 Richard Wolf GmbH
7.8.1 Company Overview
7.9 Cliniva Healthcare
7.9.1 Company Overview
7.10. OTU Medical, Inc.
7.10.1 Company Overview

Companies Mentioned

  • Boston Scientific Corporation
  • Olympus Corporation
  • Hoya Corporation
  • Steris PLC
  • Stryker Corporation
  • Advin Health Care
  • Karl Storz SE & Co. KG
  • Richard Wolf GmbH
  • Cliniva Healthcare
  • OTU Medical Inc.

Methodology

Loading
LOADING...